Results 221 to 230 of about 82,620 (274)

Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Venetoclax is a potent, oral BCL‐2 inhibitor approved as combination therapy for the treatment of adults with newly diagnosed acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy. This study evaluated the safety and preliminary efficacy of venetoclax alone or combined with chemotherapy in paediatric and ...
Seth E. Karol, Seong L. Khaw, C. Michel Zwaan, Andre Baruchel, Henrique Bittencourt, Todd M. Cooper, Christian Flotho, Christopher Fraser, Christopher J. Forlenza, Kelly C. Goldsmith, Margaret E. Macy, Daniel A. Morgenstern, Maureen M. O'Brien, Arnaud Petit, David S. Ziegler, Dirk Reinhardt, Joseph T. Opferman, Jeffrey E. Rubnitz, Maika Onishi, Diana R. Dunshee, Fengjiao Dunbar, Deeksha Vishwamitra, Jeremy A. Ross, Xin Chen, Kristina Unnebrink, Maja Kammerlander, Ahmed Hamed Salem, Tammy L. Palenski, Gauri Sunkersett, Andrew E. Place   +29 more
wiley   +1 more source

Autoimmunity promotes chronic lymphocytic leukemia progression in an indolent disease model. [PDF]

Sci Rep
Pfeuffer L, Siegert V, Trozzo R, Steiger K, Rad R, Ruland J, Buchner M.   +6 more
europepmc   +1 more source

Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells

, 1984
NE Kay, JM Zarling
openalex   +1 more source

Ocular involvement in newly diagnosed pediatric leukemia: A systematic review and meta‐analysis

Pediatric Investigation, EarlyView.
The global prevalence of ocular involvement in pediatric leukemia is estimated to be 20.32%, which is more common than previously recognized. Given the high rate of asymptomatic involvement, screening for all newly diagnosed leukemia patients is recommended.
Kristina Nazzicone, Rachel Kim, Alexa Fine, Aidan Pucchio, Laura Wheaton, Christine Law   +5 more
wiley   +1 more source

Acalabrutinib and Obinutuzumab for Chronic Lymphocytic Leukemia Complicated With Peripheral Neuropathy. [PDF]

Cureus
Edahiro T, Ureshino H, Nakamori M, Shindo T, Ichinohe T.   +4 more
europepmc   +1 more source

Comparing Venous vs. Capillary Blood Collection Methods for Proteomic Measurement in Peripheral Blood

PROTEOMICS – Clinical Applications, EarlyView.
ABSTRACT Background Capillary blood collection has a number of advantages over venous collection, especially in the context of increasing decentralized clinical trials and field‐based testing. No studies are available comparing venous versus capillary blood collection for proteomics measurement.
Mary Ni Lochlainn, Nathan J. Cheetham, Mario Falchi, Paolo Piazza, Claire J. Steves   +4 more
wiley   +1 more source

Visualization and hotspot analysis of CAR‐T research based on CiteSpace

Precision Medical Sciences, EarlyView.
Articles on CAR‐T cells were collected from the Web of Science Core Collection (WoSCC). Key bibliometric characteristics were analyzed using CiteSpace. Our findings showed that CAR‐T cell therapy is a cutting‐edge field that has drawn a lot of interest, that its depth and excitement for research are growing, and that it may face further challenges and ...
Kejin Li, Yue Teng, Weiyan Tang, Liuliu Zhang, Xiaoxu Zhi, Wenjuan Li, Jianqiu Wu   +6 more
wiley   +1 more source

Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1. [PDF]

Cancer Cell Int
Abolhasani S, Salehi Khesht AM, Khodakarami A, Masjedi A, Rashidi B, Izadi S, Noukabadi FK, Karpisheh V, Poudeh KT, Jalali P, Salehi Z, Bagherifar R, Hejazian SS, Movassaghpour A, Feizi AAH, Jadidi F.   +15 more
europepmc   +1 more source

An unveiling case of Nocardia pansinusitis in a patient with chronic lymphocytic leukemia: a case report. [PDF]

J Med Case Rep
Najafizadeh M, Kourkinejad Gharaei F, Manouchehri Ardekani R, Rafiyan M.   +3 more
europepmc   +1 more source

Hetrombopag: A promising thrombopoietin receptor agonist for the treatment of primary and secondary immune thrombocytopenia

Rheumatology &Autoimmunity, EarlyView.
This review seeks to provide a thorough synthesis of the existing literature on the role of thrombopoietin receptor agonists in the treatment of primary and secondary immune thrombocytopenia, with particular emphasis on the compound Hetrombopag. Abstract Immune thrombocytopenia (ITP) is a rare autoimmune disorder characterized by a platelet count below
Jiaqi Hu, Zhida Fu, Xia Xu, Zhengyi Jin, Xinyu Qian, Weiyu Tao, Taiyan Ma, Dongbao Zhao, Jie Gao   +8 more
wiley   +1 more source